p. 1203 - 1211
(2022/01/27)p. 20243 - 20248
(2021/08/09)p. 6892 - 6899
(2021/06/28)(2020/06/08)
(2018/06/21)
(2018/05/16)
p. 5049 - 5061
(2018/05/08)p. 16754 - 16759
(2018/11/27)p. 1037 - 1042
(2017/07/25)p. 18 - 23
(2017/02/05)p. 5964 - 5973
(2017/12/26)p. 6929 - 6934
(2016/10/14)(2017/04/14)
p. 8931 - 8934
(2015/05/27)p. 227 - 232
(2015/10/28)(2015/01/07)
p. 12321 - 12329
(2014/01/17)p. 8885 - 8898
(2013/09/23)(2013/08/15)
p. 228 - 238
(2013/03/13)p. 3481 - 3484
(2013/01/15)p. 2106 - 2109
(2011/06/25)p. 2956 - 2965
(2011/03/19)(2009/02/10)
(2009/06/27)
(2009/07/10)
(2009/09/08)
(2009/09/25)
(2009/10/06)
(2009/12/04)
(2009/12/24)
(2009/01/20)
(2009/01/20)
(2009/01/24)
(2008/06/13)
(2008/06/13)
p. 8088 - 8093
(2008/02/08)(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
1-((S)-5-Isopropyl-3,6-dimethoxy-2,5-dihydro-pyrazin-2-yl)-ethanol
acetaldehyde
DL-threonine
D-allo-threonine
(+/-)-erythro-1-(diphenylmethylene)-4-(1-methoxyethyl)-3-oxo-1,2-diazetidinium inner salt